A detailed history of Avoro Capital Advisors LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 5,666,666 shares of XENE stock, worth $216 Million. This represents 3.36% of its overall portfolio holdings.

Number of Shares
5,666,666
Previous 5,666,666 -0.0%
Holding current value
$216 Million
Previous $221 Million 0.92%
% of portfolio
3.36%
Previous 3.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$28.7 - $46.46 $22 Million - $35.6 Million
766,666 Added 15.65%
5,666,666 $261 Million
Q2 2022

Aug 15, 2022

SELL
$25.44 - $35.16 $2.16 Million - $2.99 Million
-85,000 Reduced 1.71%
4,900,000 $149 Million
Q4 2021

Feb 14, 2022

BUY
$15.6 - $35.4 $20.8 Million - $47.3 Million
1,335,000 Added 36.58%
4,985,000 $156 Million
Q1 2021

May 17, 2021

BUY
$13.65 - $21.31 $11.6 Million - $18.1 Million
850,000 Added 30.36%
3,650,000 $65.3 Million
Q2 2020

Aug 14, 2020

BUY
$10.21 - $14.9 $285,880 - $417,200
28,000 Added 1.01%
2,800,000 $35.1 Million
Q1 2020

May 15, 2020

BUY
$8.08 - $17.57 $3.01 Million - $6.54 Million
372,000 Added 15.5%
2,772,000 $31.4 Million
Q4 2018

Feb 14, 2019

BUY
$5.61 - $12.62 $183,907 - $413,708
32,782 Added 1.38%
2,400,000 $15.1 Million
Q3 2018

Nov 14, 2018

BUY
$9.0 - $14.9 $10.5 Million - $17.4 Million
1,165,100 Added 96.92%
2,367,218 $31.2 Million
Q2 2018

Aug 14, 2018

BUY
$4.8 - $9.2 $5.77 Million - $11.1 Million
1,202,118 New
1,202,118 $11.1 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.37B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.